EUVIMEDEUVIMED entdecken
Crossref

CXCL8 suppresses autophagy and promotes malignant progression in colorectal cancer through JNK/MAPK and AKT/mTOR pathways

Baowei Han, Yunshuai Wang, Jinqiu Zhang, Huizi Tang, Feng Gu, Chaohui Li, Yu Kou, Xiangming Che

Cellular Signalling · 2027-02 · 150 · 112982

DOI: 10.1016/j.cellsig.2026.112982 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cellular Signalling, 2027-02. Verfasst von Baowei Han und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, Shanxi, China; Luoyang Maternal and Child He…. Die Arbeit nennt 38 Literaturangaben. Gefördert von: Jiangsu Province Natural Science Foundation, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Autophagy plays a critical role in tumor immunity and therapeutic response, yet its prognostic and functional significance in colorectal cancer (CRC) remains incompletely understood. In this study, we constructed a prognostic model based on autophagy-related genes (ARGs) using transcriptomic and clinical data from The Cancer Genome Atlas (TCGA). Differentially expressed ARGs were identified, and those significantly associated with overall survival were selected via univariate Cox regression analysis, followed by multivariate Cox regression to establish a six-gene signature. This model effectively stratified patients into high-risk and low-risk groups, with high-risk patients showing significantly shorter survival and pronounced enrichment in tumor-related pathways, immune infiltration, and cytokine-cytokine receptor interactions. Weighted gene co-expression network analysis (WGCNA) identified CXCL8 as a central hub gene showing weak to modest correlations with selected DNA-repair transcripts, and linked to metabolism and chemosensitivity, which was further validated in an independent GEO cohort (GSE39582), demonstrating the model's robustness and generalizability. Functional assays revealed that CXCL8 significantly promoted CRC cell proliferation, migration, invasion, and epithelial-mesenchymal transition (EMT) in vitro, as well as tumor growth in a subcutaneous xenograft model in vivo. Mechanistically, CXCL8-driven malignant phenotypes were associated with concurrent autophagic flux suppression and activation of the JNK/MAPK and AKT/mTOR pathways. Pharmacological inhibition of either pathway partially reversed CXCL8 mediated malignant phenotypes, supporting a cooperative role of these pathways in CXCL8-driven progression. Notably, lysosomal inhibitors reduced rather than enhanced malignant phenotypes in CXCL8-overexpressing cells, consistent with intrinsic drug-sensitivity effects; a causal mediatory role of autophagy therefore remains to be established by genetic rescue experiments. Collectively, these findings highlight the clinical relevance of autophagy-related signatures in CRC, provide a robust prognostic model with independent external validation, and identify CXCL8 as a potential therapeutic target showing weak to modest correlations with selected DNA-repair transcripts, whose malignant effects are associated with autophagy suppression via dual signaling pathways.

Schlagwörter

Stichwörter der Autor:innen

Autophagy-related genesCXCL8Colorectal cancerImmune cell infiltrationPrognostic signature

Autor:innen und Institutionen

  • Department of General Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, Shanxi, China; Luoyang Maternal and Child Health Hospital, China.
  • Department of General Surgery, Luoyang Central Hospital Affiliated of Zhengzhou University, China.
  • School of Traditional Chinese Medicine, Faculty of Medicine, Yangzhou University, Yangzhou 225009, China; NATCM Key Laboratory of Syndrome Differentiation and Treatment of Gastric Cancer, Yangzhou, 225009, China.
  • School of Traditional Chinese Medicine, Faculty of Medicine, Yangzhou University, Yangzhou 225009, China; NATCM Key Laboratory of Syndrome Differentiation and Treatment of Gastric Cancer, Yangzhou, 225009, China. Electr…
  • Department of General Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, Shanxi, China. Electronic address: chexiang@mail.xjtu.edu.cn.

Förderung

  • Jiangsu Province Natural Science Foundation
  • National Natural Science Foundation of China

Zitieren

APA

Han, B., Wang, Y., Zhang, J., Tang, H., Gu, F., Li, C., Kou, Y., & Che, X. (2027). CXCL8 suppresses autophagy and promotes malignant progression in colorectal cancer through JNK/MAPK and AKT/mTOR pathways. Cellular Signalling, 150, 112982. https://doi.org/10.1016/j.cellsig.2026.112982

Vancouver

Han B, Wang Y, Zhang J, Tang H, Gu F, Li C, et al. CXCL8 suppresses autophagy and promotes malignant progression in colorectal cancer through JNK/MAPK and AKT/mTOR pathways. Cellular Signalling. 2027;150:112982. doi:10.1016/j.cellsig.2026.112982

BibTeX
@article{Han2027,
  author = {Han, Baowei and Wang, Yunshuai and Zhang, Jinqiu and Tang, Huizi and Gu, Feng and Li, Chaohui and Kou, Yu and Che, Xiangming},
  title = {CXCL8 suppresses autophagy and promotes malignant progression in colorectal cancer through JNK/MAPK and AKT/mTOR pathways},
  journal = {Cellular Signalling},
  year = {2027},
  volume = {150},
  pages = {112982},
  doi = {10.1016/j.cellsig.2026.112982}
}
Kostenlos starten →